SlideShare une entreprise Scribd logo
1  sur  23
Prepared By:
Ms. Jyoti Rani
Assistant
Professor
BUEST,SPES
CONTENTS
 Introduction to QSAR
 QSAR Analysis models
 3D QSAR
 COMFA
 COMSIA
 Applications
 Case study
INTRODUCTION TO QSAR
 To relate the biological activity of a series of compounds to their
physicochemical parameters in a quantitative fashion using a
mathematical formula.
 The fundamental principle involved is difference in structural properties
is responsible for variations in biological activities of the compound.
 Physico-chemical parameters:
1. Hydrophobicity of substituents
2. Hydrophobicity of the molecule
3. Electronic properties of substituents
4. Steric properties of substituents
QSAR Analysis models
 Hansch Analysis: Corelates biological activity with physico-chemical
parsmeters.
Log(1/c) = k1 log P + k2 σ + k3 Es + k4
 Free-Wilson Analysis: Corelates biological activity with certain
structural features of the compound.
 Limitation:
1. Does not consider 3D structure.
2. No graphical output thereby making the interpretation of results in
familiar chemical terms, frequently difficult if not impossible
3D QSAR
 3D QSAR is an extension of classical QSAR which exploits the 3 dimensional
properties of the ligands to predict their biological activity using robust stastical
analysis like PLS, G/PLS, ANN etc.
 3D-QSAR uses probe-based sampling within a molecular lattice to determine three-
dimensional properties of molecules and can then correlate these 3D descriptors with
biological activity.
 No QSAR model can replace the experimental assays, though experimental
techniques are also not free from errors.
 Some of the major factors like desolvation energetics, temperature, diffusion,
transport, pH, salt concentration etc. which contribute to the overall free energy of
binding are difficult to handle, and thus usually ignored.
 Regardless of all such problems, 3D-QSAR becomes a useful alternative approach.
Statistical Techniques for Building QSAR Models
CoMFA(Comparative Molecular Field
Analysis)
 In 1987, Cramer developed the predecessor of 3D approaches called Dynamic
Lattice-Oriented Molecular Modeling System (DYLOMMS) that involves the
use of PCA to extract vectors from the molecular interaction fields, which are
then correlated with biological activities.
 Soon after he modified it by combining the two existing techniques, GRID and
PLS, to develop a powerful 3D QSAR methodology, Comparative Molecular
Field Analysis (CoMFA).
 The underlying idea of CoMFA is that differences in a target property, e.g.,
biological activity, are often closely related to equivalent changes in shapes
and strengths of non-covalent interaction fields surrounding the molecules.
 Hence, the molecules are placed in a cubic grid and the interaction energies
between the molecule and a defined probe are calculated for each grid point.
Protocol for CoMFA:
 A standard CoMFA procedure, as implemented in the Sybyl Software, follows the following
sequential steps:
1. Bioactive conformations of each molecule are determined.
2. All the molecules are superimposed or aligned using either manual or automated methods, in
a manner defined by the supposed mode of interaction with the receptor.
3. The overlaid molecules are placed in the center of a lattice grid with a spacing of 2 Å.
4. The algorithm compares, in three-dimensions, the steric and electrostatic fields calculated
around the molecules with different probe groups positioned at all intersections of the lattice.
5. The interaction energy or field values are correlated with the biological activity data using
PLS technique, which identifies and extracts the quantitative influence of specific chemical
features of molecules on their biological activity.
6. The results are articulated as correlation equations with the number of latent variable terms,
each of which is a linear combination of original independent lattice descriptors.
7. For visual understanding, the PLS output is presented in the form of an interactive graphics
consisting of colored contour plots of coefficients of the corresponding field variables at each
lattice intersection, and showing the imperative favorable and unfavorable regions in three
dimensional space which are considerably associated with the biological activity.
DRAWBACKS AND LIMITATIONS
OF CoMFA
 CoMFA has several pitfalls and imperfections:
1. Too many adjustable parameters like overall orientation, lattice placement, step size,
probe atom type etc.
2. Uncertainty in selection of compounds and variables
3. Fragmented contour maps with variable selection procedures
4. Hydrophobicity not well-quantified
5. Cut-off limits used
6. Low signal to noise ratio due to many useless field variables
7. Imperfections in potential energy functions
8. Various practical problems with PLS
9. Applicable only to in vitro data
Comparative Molecular Similarity Indices Analysis
(CoMSIA)
 CoMSIA was developed to overcome certain limitations of CoMFA.
 In CoMSIA, molecular similarity indices calculated from modified SEAL similarity
fields are employed as descriptors to simultaneously consider steric, electrostatic,
hydrophobic and hydrogen bonding properties.
 These indices are estimated indirectly by comparing the similarity of each
molecule in the dataset with a common probe atom (having a radius of 1 Å,
charge of +1 and hydrophobicity of +1) positioned at the intersections of a
surrounding grid/lattice.
 For computing similarity at all grid points, the mutual distances between the probe
atom and the atoms of the molecules in the aligned dataset are also taken into
account.
 To describe this distance-dependence and calculate the molecular properties, Gaussian-type
functions are employed. Since the underlying Gaussian-type functional forms are ‘smooth’
with no singularities, their slopes are not as steep as the Coulombic and Lennard-Jones
potentials in CoMFA; therefore, no arbitrary cut- off limits are required to be defined.
 CoMSIA is provided by Tripos Inc. in the Sybyl software, along with CoMFA.
The Comparison of CoMFA and CoMSIA
APPLICATIONS:
1. QSAR in Chromatography: Quantitative Structure–Retention
Relationships (QSRRs)
2. The Use of QSAR and Computational Methods in Drug Design.
3. In Silico Approaches for Predicting ADME Properties.
4. Prediction of Harmful Human Health Effects of Chemicals from Structure.
5. Chemometric Methods and Theoretical Molecular Descriptors in Predictive
QSAR Modeling of the Environmental Behavior of Organic Pollutants.
6. The Role of QSAR Methodology in the Regulatory Assessment of
Chemicals.
7. Nanomaterials – the Great Challenge for QSAR Modelers
Case study:Human Eosinophil
Phosphodiesterase •
 The phosphodiesterase type IV (PDE4) plays an important role
in regulating intracellular levels of cAMP and cGMP.
 PDE4 has highly expressed in inflammatory and immune cells
and airway smooth muscle and degrade the cAMP’s
concentration.
 The inhibition of PDE4 increase the intracellular cAMP
concentrations to kill inflammatory cells and relax airway
smooth muscle.
 To develop the selective PDE4 inhibitors as anti-inflammatory
and asthmatic drugs has attracted extensive research has been
conducted. The QSAR studies of PDE4 inhibitors have also
been done by using CoMFA and CoMSIA methods.
 More potent and selective PDE4 inhibitors, a series of 5,6-dihydro-(9H) -
pyrazolo[3,4-c] -1,2,4-triazolo [4,3R]pyridine, were improved and synthesized
based on the structures of 7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]
pyridine.
 In order to study the interaction mechanism of PDE4 with 31 new
compounds, the QSAR model was built by using the CoMFA. 5,6-dihydro-
(9H) -pyrazolo[3,4- c] -1,2,4-triazolo [4,3R]pyridine
Structures of 5, 6-Dihydro-(9H)-pyrazolo[3,4-c]-
1,2,4-triazolo[4,3-a]pyridines.
The superstition of 31structures of
5,6-Dihydro-(9H)-pyrazolo[3,4-c]-1,2,4-
triazolo[4,3-α] pyridines.
Four compounds were randomly selected as test set, other twenty-seven
compounds as training set.
Method:
 The structures of 31 compounds were built with molecular sketch program.
 Then Gasteiger-Hückel charges were assigned to each atom and the
energy minimization of each molecule.
 All the compounds studied had common rigid substructure. Therefore, the
common rigid substructure alignment was carried out by using database
alignment tool.
 The most active compound cyclobutyl substituent is used as template
molecule.
 All aligned molecules were put into a 3D cubic lattice that extending at least
4 Å beyond the volumes of all investigated molecules on all axes.
 In the 3D lattice, the grid spacing was set to 2.0 Å in the x, y, and z
directions.
 A sp3 hybrized carbon atom with a charge of +1 was used as the probe
atom, CoMFA steric and electrostatic interaction fields were calculated.
Method contd.
 Partial least squares (PLS) method was carried out to build the 3D-QSAR models.
Leave-one- out (LOO) cross-validated PLS analysis was used to check the
predictive ability of the models and to determine the optimal number of components
to be used in the final QSAR models.
 The PLS analysis gave a CoMFA model with cross-validated q2 value of 0.565 for 3
optimal components. The non-cross-validated PLS analysis of these compounds
was repeated with the optimal number of components and the R2 value was 0.867.
The correlation plot of experimental values vs
the predicted values was shown in Plot of the
predicted pIC50 vs experimental pIC50
• The interacting mode of compound with
protein.
• The inhibitors and the important residues for
inhibitor-protein interaction are represented
by ball-and-stick models, respectively.
• The green dashed lines denote the hydrogen
bonds.
Structures of Erβ protein binding with
compounds obtained from molecular
docking
Contour Maps of CoMFA
Model
Contour plots of the CoMFA steric fields (left) and electrostatic fields (right) of
compound No. 24
3 D QSAR Approaches and Contour Map Analysis
CONCLUSION
 CoMFA and CoMSIA are useful techniques in understanding
pharmacological properties of studied compounds, and they
have been successfully used in modern drug design.
 Despite of all the pitfalls it has now been globally used for drug
discovery based on well-established principles of statistics, is
intrinsically a valuable and viable medicinal chemistry tool
whose application domain range from explaining the structure-
activity relationships quantitatively and retrospectively, to
endowing synthetic guidance leading to logical and
experimentally testable hypotheses.
 Apart from synthetic applications it has also been used in
various other fields too.
Reference
 An Introduction to Medicinal Chemistry FIFTH EDITION
by Graham L. Patrick
 Yuhong Xiang, Zhuoyong Zhang*, Aijing Xiao, and Jinxu
Huo “Recent Studies of QSAR on Inhibitors of Estrogen
Receptor and Human Eosinophil Phosphodiesterase”
Department of Chemistry, Capital Normal University,
Beijing 100048, P.R. China
 Jitender Verma, Vijay M. Khedkar and Evans C. Coutinho
“3D-QSAR in Drug Design - A Review” Department of
Pharmaceutical Chemistry, Bombay College of Pharmacy,
Kalina, Santacruz (E), Mumbai 400 098, India
Thank you

Contenu connexe

Tendances

in silico drug design and virtual screening technique
 in silico drug design and virtual screening technique in silico drug design and virtual screening technique
in silico drug design and virtual screening techniqueMO.SHAHANAWAZ
 
Pharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screeningPharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screeningSanchit Dhankhar
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)Pinky Vincent
 
conformational search used in Pharmacophore mapping
conformational search used in Pharmacophore mappingconformational search used in Pharmacophore mapping
conformational search used in Pharmacophore mappingVishakha Giradkar
 
(Kartik Tiwari) Denovo Drug Design.pptx
(Kartik Tiwari) Denovo Drug Design.pptx(Kartik Tiwari) Denovo Drug Design.pptx
(Kartik Tiwari) Denovo Drug Design.pptxKartik Tiwari
 
Molecular and Quantum Mechanics in drug design
Molecular and Quantum Mechanics in drug designMolecular and Quantum Mechanics in drug design
Molecular and Quantum Mechanics in drug designAjay Kumar
 
Quantitative structure activity relationships
Quantitative structure  activity relationshipsQuantitative structure  activity relationships
Quantitative structure activity relationshipsAmiya ghosh
 
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxPREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxMO.SHAHANAWAZ
 
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)Satigayatri
 
Pharmacophore mapping
Pharmacophore mapping Pharmacophore mapping
Pharmacophore mapping GamitKinjal
 
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDQSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDGagangowda58
 
Structure based in silico virtual screening
Structure based in silico virtual screeningStructure based in silico virtual screening
Structure based in silico virtual screeningJoon Jyoti Sahariah
 
Presentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screeningPresentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screeningJoon Jyoti Sahariah
 
In Silico methods for ADMET prediction of new molecules
 In Silico methods for ADMET prediction of new molecules In Silico methods for ADMET prediction of new molecules
In Silico methods for ADMET prediction of new moleculesMadhuraDatar
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Theabhi.in
 
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARMDENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARMShikha Popali
 
De novo drug design
De novo drug designDe novo drug design
De novo drug designmojdeh y
 
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptxMOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptxMO.SHAHANAWAZ
 
Pharmacophore mapping.pptx
Pharmacophore mapping.pptxPharmacophore mapping.pptx
Pharmacophore mapping.pptxARIFULISLAM617
 

Tendances (20)

De Novo Drug Design
De Novo Drug DesignDe Novo Drug Design
De Novo Drug Design
 
in silico drug design and virtual screening technique
 in silico drug design and virtual screening technique in silico drug design and virtual screening technique
in silico drug design and virtual screening technique
 
Pharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screeningPharmacophore mapping and virtual screening
Pharmacophore mapping and virtual screening
 
CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)CoMFA CoMFA Comparative Molecular Field Analysis)
CoMFA CoMFA Comparative Molecular Field Analysis)
 
conformational search used in Pharmacophore mapping
conformational search used in Pharmacophore mappingconformational search used in Pharmacophore mapping
conformational search used in Pharmacophore mapping
 
(Kartik Tiwari) Denovo Drug Design.pptx
(Kartik Tiwari) Denovo Drug Design.pptx(Kartik Tiwari) Denovo Drug Design.pptx
(Kartik Tiwari) Denovo Drug Design.pptx
 
Molecular and Quantum Mechanics in drug design
Molecular and Quantum Mechanics in drug designMolecular and Quantum Mechanics in drug design
Molecular and Quantum Mechanics in drug design
 
Quantitative structure activity relationships
Quantitative structure  activity relationshipsQuantitative structure  activity relationships
Quantitative structure activity relationships
 
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptxPREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
PREDICTION AND ANALYSIS OF ADMET PROPERTIES OF NEW.pptx
 
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
QSAR statistical methods for drug discovery(pharmacology m.pharm2nd sem)
 
Pharmacophore mapping
Pharmacophore mapping Pharmacophore mapping
Pharmacophore mapping
 
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADDQSAR applications: Hansch analysis and Free Wilson analysis, CADD
QSAR applications: Hansch analysis and Free Wilson analysis, CADD
 
Structure based in silico virtual screening
Structure based in silico virtual screeningStructure based in silico virtual screening
Structure based in silico virtual screening
 
Presentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screeningPresentation on insilico drug design and virtual screening
Presentation on insilico drug design and virtual screening
 
In Silico methods for ADMET prediction of new molecules
 In Silico methods for ADMET prediction of new molecules In Silico methods for ADMET prediction of new molecules
In Silico methods for ADMET prediction of new molecules
 
Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)Quantitative Structure Activity Relationship (QSAR)
Quantitative Structure Activity Relationship (QSAR)
 
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARMDENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
 
De novo drug design
De novo drug designDe novo drug design
De novo drug design
 
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptxMOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
MOLECULAR DOCKING AND DRUG RECEPTOR INTERACTION AGENT ACTING.pptx
 
Pharmacophore mapping.pptx
Pharmacophore mapping.pptxPharmacophore mapping.pptx
Pharmacophore mapping.pptx
 

Similaire à 3 D QSAR Approaches and Contour Map Analysis

Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipRaniBhagat1
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Atai Rabby
 
Quantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptxQuantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptxRadhaChafle1
 
2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA values2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA valuesvarun Kundi
 
IJBB-51-3-188-200
IJBB-51-3-188-200IJBB-51-3-188-200
IJBB-51-3-188-200sankar basu
 
consensus superiority of the pharmacophore based alignment, over maximum comm...
consensus superiority of the pharmacophore based alignment, over maximum comm...consensus superiority of the pharmacophore based alignment, over maximum comm...
consensus superiority of the pharmacophore based alignment, over maximum comm...Deepak Rohilla
 
Lecture 5 pharmacophore and qsar
Lecture 5  pharmacophore and  qsarLecture 5  pharmacophore and  qsar
Lecture 5 pharmacophore and qsarRAJAN ROLTA
 
QSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureQSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureSaramita De Chakravarti
 
QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship ZarlishAttique1
 
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...ijcisjournal
 
Treatment by alternative methods of regression gas chromatographic retention ...
Treatment by alternative methods of regression gas chromatographic retention ...Treatment by alternative methods of regression gas chromatographic retention ...
Treatment by alternative methods of regression gas chromatographic retention ...ijics
 
Cloud Pharmaceuticals white paper.LIE_2016
Cloud Pharmaceuticals white paper.LIE_2016Cloud Pharmaceuticals white paper.LIE_2016
Cloud Pharmaceuticals white paper.LIE_2016Shahar Keinan
 
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...ijsc
 
Main_Ms_JBNMR_Final_version
Main_Ms_JBNMR_Final_versionMain_Ms_JBNMR_Final_version
Main_Ms_JBNMR_Final_versionAbhilash Kannan
 

Similaire à 3 D QSAR Approaches and Contour Map Analysis (20)

Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity Relationship
 
Qsar
QsarQsar
Qsar
 
Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
 
QSAR by Faizan Deshmukh
QSAR by Faizan DeshmukhQSAR by Faizan Deshmukh
QSAR by Faizan Deshmukh
 
Quantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptxQuantitative Structure Activity Relationship.pptx
Quantitative Structure Activity Relationship.pptx
 
2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA values2015 New trans-stilbene derivatives with large TPA values
2015 New trans-stilbene derivatives with large TPA values
 
IJBB-51-3-188-200
IJBB-51-3-188-200IJBB-51-3-188-200
IJBB-51-3-188-200
 
consensus superiority of the pharmacophore based alignment, over maximum comm...
consensus superiority of the pharmacophore based alignment, over maximum comm...consensus superiority of the pharmacophore based alignment, over maximum comm...
consensus superiority of the pharmacophore based alignment, over maximum comm...
 
Lanjutan kimed
Lanjutan kimedLanjutan kimed
Lanjutan kimed
 
QSPR For Pharmacokinetics
QSPR For PharmacokineticsQSPR For Pharmacokinetics
QSPR For Pharmacokinetics
 
Lecture 5 pharmacophore and qsar
Lecture 5  pharmacophore and  qsarLecture 5  pharmacophore and  qsar
Lecture 5 pharmacophore and qsar
 
QSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative StructureQSAR : Activity Relationships Quantitative Structure
QSAR : Activity Relationships Quantitative Structure
 
acs.jpca.9b08723.pdf
acs.jpca.9b08723.pdfacs.jpca.9b08723.pdf
acs.jpca.9b08723.pdf
 
QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship QSAR quantitative structure activity relationship
QSAR quantitative structure activity relationship
 
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...
 
Treatment by alternative methods of regression gas chromatographic retention ...
Treatment by alternative methods of regression gas chromatographic retention ...Treatment by alternative methods of regression gas chromatographic retention ...
Treatment by alternative methods of regression gas chromatographic retention ...
 
Cloud Pharmaceuticals white paper.LIE_2016
Cloud Pharmaceuticals white paper.LIE_2016Cloud Pharmaceuticals white paper.LIE_2016
Cloud Pharmaceuticals white paper.LIE_2016
 
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...
TREATMENT BY ALTERNATIVE METHODS OF REGRESSION GAS CHROMATOGRAPHIC RETENTION ...
 
Main_Ms_JBNMR_Final_version
Main_Ms_JBNMR_Final_versionMain_Ms_JBNMR_Final_version
Main_Ms_JBNMR_Final_version
 
QSAR.pptx
QSAR.pptxQSAR.pptx
QSAR.pptx
 

Plus de Baddi University of Emerging sciences and Technology (7)

Drugs Acting on CNS-Antipsychotics
Drugs Acting on CNS-AntipsychoticsDrugs Acting on CNS-Antipsychotics
Drugs Acting on CNS-Antipsychotics
 
Drugs acting on cns sedative and hypnotics
Drugs acting on cns sedative and hypnoticsDrugs acting on cns sedative and hypnotics
Drugs acting on cns sedative and hypnotics
 
Drugs acting on cns general anaesthics
Drugs acting on cns general anaesthicsDrugs acting on cns general anaesthics
Drugs acting on cns general anaesthics
 
Drugs acting on cns anticonvulsants
Drugs acting on cns anticonvulsantsDrugs acting on cns anticonvulsants
Drugs acting on cns anticonvulsants
 
Overview of the autonomic nervous system
Overview of the autonomic nervous systemOverview of the autonomic nervous system
Overview of the autonomic nervous system
 
Adrenergics and anti adrenergics
Adrenergics and anti adrenergicsAdrenergics and anti adrenergics
Adrenergics and anti adrenergics
 
Cholinergics and anti cholinergic drugs
Cholinergics and anti cholinergic drugsCholinergics and anti cholinergic drugs
Cholinergics and anti cholinergic drugs
 

Dernier

The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice documentXsasf Sfdfasd
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...CaraSkikne1
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxheathfieldcps1
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesMohammad Hassany
 
Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...raviapr7
 
Philosophy of Education and Educational Philosophy
Philosophy of Education  and Educational PhilosophyPhilosophy of Education  and Educational Philosophy
Philosophy of Education and Educational PhilosophyShuvankar Madhu
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfMohonDas
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.EnglishCEIPdeSigeiro
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfTechSoup
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxEduSkills OECD
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptxraviapr7
 
How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17Celine George
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17Celine George
 
M-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxM-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxDr. Santhosh Kumar. N
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and stepobaje godwin sunday
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsEugene Lysak
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfMohonDas
 

Dernier (20)

The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice document
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptx
 
Human-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming ClassesHuman-AI Co-Creation of Worked Examples for Programming Classes
Human-AI Co-Creation of Worked Examples for Programming Classes
 
Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...
 
Philosophy of Education and Educational Philosophy
Philosophy of Education  and Educational PhilosophyPhilosophy of Education  and Educational Philosophy
Philosophy of Education and Educational Philosophy
 
Diploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdfDiploma in Nursing Admission Test Question Solution 2023.pdf
Diploma in Nursing Admission Test Question Solution 2023.pdf
 
Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.Easter in the USA presentation by Chloe.
Easter in the USA presentation by Chloe.
 
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdfMaximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
Maximizing Impact_ Nonprofit Website Planning, Budgeting, and Design.pdf
 
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptxPISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
PISA-VET launch_El Iza Mohamedou_19 March 2024.pptx
 
Prelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quizPrelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quiz
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17How to Use api.constrains ( ) in Odoo 17
How to Use api.constrains ( ) in Odoo 17
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
How to Solve Singleton Error in the Odoo 17
How to Solve Singleton Error in the  Odoo 17How to Solve Singleton Error in the  Odoo 17
How to Solve Singleton Error in the Odoo 17
 
M-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptxM-2- General Reactions of amino acids.pptx
M-2- General Reactions of amino acids.pptx
 
General views of Histopathology and step
General views of Histopathology and stepGeneral views of Histopathology and step
General views of Histopathology and step
 
The Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George WellsThe Stolen Bacillus by Herbert George Wells
The Stolen Bacillus by Herbert George Wells
 
HED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdfHED Office Sohayok Exam Question Solution 2023.pdf
HED Office Sohayok Exam Question Solution 2023.pdf
 

3 D QSAR Approaches and Contour Map Analysis

  • 1. Prepared By: Ms. Jyoti Rani Assistant Professor BUEST,SPES
  • 2. CONTENTS  Introduction to QSAR  QSAR Analysis models  3D QSAR  COMFA  COMSIA  Applications  Case study
  • 3. INTRODUCTION TO QSAR  To relate the biological activity of a series of compounds to their physicochemical parameters in a quantitative fashion using a mathematical formula.  The fundamental principle involved is difference in structural properties is responsible for variations in biological activities of the compound.  Physico-chemical parameters: 1. Hydrophobicity of substituents 2. Hydrophobicity of the molecule 3. Electronic properties of substituents 4. Steric properties of substituents
  • 4. QSAR Analysis models  Hansch Analysis: Corelates biological activity with physico-chemical parsmeters. Log(1/c) = k1 log P + k2 σ + k3 Es + k4  Free-Wilson Analysis: Corelates biological activity with certain structural features of the compound.  Limitation: 1. Does not consider 3D structure. 2. No graphical output thereby making the interpretation of results in familiar chemical terms, frequently difficult if not impossible
  • 5. 3D QSAR  3D QSAR is an extension of classical QSAR which exploits the 3 dimensional properties of the ligands to predict their biological activity using robust stastical analysis like PLS, G/PLS, ANN etc.  3D-QSAR uses probe-based sampling within a molecular lattice to determine three- dimensional properties of molecules and can then correlate these 3D descriptors with biological activity.  No QSAR model can replace the experimental assays, though experimental techniques are also not free from errors.  Some of the major factors like desolvation energetics, temperature, diffusion, transport, pH, salt concentration etc. which contribute to the overall free energy of binding are difficult to handle, and thus usually ignored.  Regardless of all such problems, 3D-QSAR becomes a useful alternative approach.
  • 6. Statistical Techniques for Building QSAR Models
  • 7. CoMFA(Comparative Molecular Field Analysis)  In 1987, Cramer developed the predecessor of 3D approaches called Dynamic Lattice-Oriented Molecular Modeling System (DYLOMMS) that involves the use of PCA to extract vectors from the molecular interaction fields, which are then correlated with biological activities.  Soon after he modified it by combining the two existing techniques, GRID and PLS, to develop a powerful 3D QSAR methodology, Comparative Molecular Field Analysis (CoMFA).  The underlying idea of CoMFA is that differences in a target property, e.g., biological activity, are often closely related to equivalent changes in shapes and strengths of non-covalent interaction fields surrounding the molecules.  Hence, the molecules are placed in a cubic grid and the interaction energies between the molecule and a defined probe are calculated for each grid point.
  • 8. Protocol for CoMFA:  A standard CoMFA procedure, as implemented in the Sybyl Software, follows the following sequential steps: 1. Bioactive conformations of each molecule are determined. 2. All the molecules are superimposed or aligned using either manual or automated methods, in a manner defined by the supposed mode of interaction with the receptor. 3. The overlaid molecules are placed in the center of a lattice grid with a spacing of 2 Å. 4. The algorithm compares, in three-dimensions, the steric and electrostatic fields calculated around the molecules with different probe groups positioned at all intersections of the lattice. 5. The interaction energy or field values are correlated with the biological activity data using PLS technique, which identifies and extracts the quantitative influence of specific chemical features of molecules on their biological activity. 6. The results are articulated as correlation equations with the number of latent variable terms, each of which is a linear combination of original independent lattice descriptors. 7. For visual understanding, the PLS output is presented in the form of an interactive graphics consisting of colored contour plots of coefficients of the corresponding field variables at each lattice intersection, and showing the imperative favorable and unfavorable regions in three dimensional space which are considerably associated with the biological activity.
  • 9. DRAWBACKS AND LIMITATIONS OF CoMFA  CoMFA has several pitfalls and imperfections: 1. Too many adjustable parameters like overall orientation, lattice placement, step size, probe atom type etc. 2. Uncertainty in selection of compounds and variables 3. Fragmented contour maps with variable selection procedures 4. Hydrophobicity not well-quantified 5. Cut-off limits used 6. Low signal to noise ratio due to many useless field variables 7. Imperfections in potential energy functions 8. Various practical problems with PLS 9. Applicable only to in vitro data
  • 10. Comparative Molecular Similarity Indices Analysis (CoMSIA)  CoMSIA was developed to overcome certain limitations of CoMFA.  In CoMSIA, molecular similarity indices calculated from modified SEAL similarity fields are employed as descriptors to simultaneously consider steric, electrostatic, hydrophobic and hydrogen bonding properties.  These indices are estimated indirectly by comparing the similarity of each molecule in the dataset with a common probe atom (having a radius of 1 Å, charge of +1 and hydrophobicity of +1) positioned at the intersections of a surrounding grid/lattice.  For computing similarity at all grid points, the mutual distances between the probe atom and the atoms of the molecules in the aligned dataset are also taken into account.
  • 11.  To describe this distance-dependence and calculate the molecular properties, Gaussian-type functions are employed. Since the underlying Gaussian-type functional forms are ‘smooth’ with no singularities, their slopes are not as steep as the Coulombic and Lennard-Jones potentials in CoMFA; therefore, no arbitrary cut- off limits are required to be defined.  CoMSIA is provided by Tripos Inc. in the Sybyl software, along with CoMFA. The Comparison of CoMFA and CoMSIA
  • 12. APPLICATIONS: 1. QSAR in Chromatography: Quantitative Structure–Retention Relationships (QSRRs) 2. The Use of QSAR and Computational Methods in Drug Design. 3. In Silico Approaches for Predicting ADME Properties. 4. Prediction of Harmful Human Health Effects of Chemicals from Structure. 5. Chemometric Methods and Theoretical Molecular Descriptors in Predictive QSAR Modeling of the Environmental Behavior of Organic Pollutants. 6. The Role of QSAR Methodology in the Regulatory Assessment of Chemicals. 7. Nanomaterials – the Great Challenge for QSAR Modelers
  • 13. Case study:Human Eosinophil Phosphodiesterase •  The phosphodiesterase type IV (PDE4) plays an important role in regulating intracellular levels of cAMP and cGMP.  PDE4 has highly expressed in inflammatory and immune cells and airway smooth muscle and degrade the cAMP’s concentration.  The inhibition of PDE4 increase the intracellular cAMP concentrations to kill inflammatory cells and relax airway smooth muscle.  To develop the selective PDE4 inhibitors as anti-inflammatory and asthmatic drugs has attracted extensive research has been conducted. The QSAR studies of PDE4 inhibitors have also been done by using CoMFA and CoMSIA methods.
  • 14.  More potent and selective PDE4 inhibitors, a series of 5,6-dihydro-(9H) - pyrazolo[3,4-c] -1,2,4-triazolo [4,3R]pyridine, were improved and synthesized based on the structures of 7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c] pyridine.  In order to study the interaction mechanism of PDE4 with 31 new compounds, the QSAR model was built by using the CoMFA. 5,6-dihydro- (9H) -pyrazolo[3,4- c] -1,2,4-triazolo [4,3R]pyridine Structures of 5, 6-Dihydro-(9H)-pyrazolo[3,4-c]- 1,2,4-triazolo[4,3-a]pyridines. The superstition of 31structures of 5,6-Dihydro-(9H)-pyrazolo[3,4-c]-1,2,4- triazolo[4,3-α] pyridines.
  • 15. Four compounds were randomly selected as test set, other twenty-seven compounds as training set.
  • 16. Method:  The structures of 31 compounds were built with molecular sketch program.  Then Gasteiger-Hückel charges were assigned to each atom and the energy minimization of each molecule.  All the compounds studied had common rigid substructure. Therefore, the common rigid substructure alignment was carried out by using database alignment tool.  The most active compound cyclobutyl substituent is used as template molecule.  All aligned molecules were put into a 3D cubic lattice that extending at least 4 Å beyond the volumes of all investigated molecules on all axes.  In the 3D lattice, the grid spacing was set to 2.0 Å in the x, y, and z directions.  A sp3 hybrized carbon atom with a charge of +1 was used as the probe atom, CoMFA steric and electrostatic interaction fields were calculated.
  • 17. Method contd.  Partial least squares (PLS) method was carried out to build the 3D-QSAR models. Leave-one- out (LOO) cross-validated PLS analysis was used to check the predictive ability of the models and to determine the optimal number of components to be used in the final QSAR models.  The PLS analysis gave a CoMFA model with cross-validated q2 value of 0.565 for 3 optimal components. The non-cross-validated PLS analysis of these compounds was repeated with the optimal number of components and the R2 value was 0.867. The correlation plot of experimental values vs the predicted values was shown in Plot of the predicted pIC50 vs experimental pIC50
  • 18. • The interacting mode of compound with protein. • The inhibitors and the important residues for inhibitor-protein interaction are represented by ball-and-stick models, respectively. • The green dashed lines denote the hydrogen bonds. Structures of Erβ protein binding with compounds obtained from molecular docking
  • 19. Contour Maps of CoMFA Model Contour plots of the CoMFA steric fields (left) and electrostatic fields (right) of compound No. 24
  • 21. CONCLUSION  CoMFA and CoMSIA are useful techniques in understanding pharmacological properties of studied compounds, and they have been successfully used in modern drug design.  Despite of all the pitfalls it has now been globally used for drug discovery based on well-established principles of statistics, is intrinsically a valuable and viable medicinal chemistry tool whose application domain range from explaining the structure- activity relationships quantitatively and retrospectively, to endowing synthetic guidance leading to logical and experimentally testable hypotheses.  Apart from synthetic applications it has also been used in various other fields too.
  • 22. Reference  An Introduction to Medicinal Chemistry FIFTH EDITION by Graham L. Patrick  Yuhong Xiang, Zhuoyong Zhang*, Aijing Xiao, and Jinxu Huo “Recent Studies of QSAR on Inhibitors of Estrogen Receptor and Human Eosinophil Phosphodiesterase” Department of Chemistry, Capital Normal University, Beijing 100048, P.R. China  Jitender Verma, Vijay M. Khedkar and Evans C. Coutinho “3D-QSAR in Drug Design - A Review” Department of Pharmaceutical Chemistry, Bombay College of Pharmacy, Kalina, Santacruz (E), Mumbai 400 098, India